FYI, TGEN apparently has two poster presentations at ASCO
Activity of E1a in Human Clinical Trials. - T Reynolds, D Alberts, D Gershenson, L Gleich, B Glisson, E Hanna, L Huang, M Hung, D Kenady, N Ueno, D Villaret, G Yoo, Targeted Genetics Corp, Seattle, WA; U of Arizona, Tucson, AZ; MD Anderson Cancer Ctr, Houston, TX; U of Cincinnati, Cincinnati, OH; U of Arkansas, Little Rock, AR; U of Pittsburgh, Pittsburgh, PA; U of Kentucky, Lexington, KY; U of Florida, Gainesville, FL; Wayne State Univ, Detroit, MI. Sunday 5/21/00, 1:00 PM - 5:00 PM Ernest N. Morial Convention Center , R06 - R07 (2nd Floor Riverside - Escalators 1 & 2)
Downregulation of HER2, Induction of Apoptosis, and Increase in TNF-a Level After E1A Gene Therapy in Patients with Advanced Breast/Ovarian Cancers. - N Ueno, W Xia, S Zhang, C Bartholomeusz, J Wolf, D Gershenson, L Huang, G Lopez-Berestein, G Hortobagyi, P Anklesaria, M Hung, M D Andeson Cancer Ctr, Houston, TX; Univ of Pittsburgh, Pittsburgh, PA; Targeted Genetics Corp, Seattle, WA. Sunday 5/21/00, 1:00 PM - 5:00 PM Ernest N. Morial Convention Center , R06 - R07 (2nd Floor Riverside - Escalators 1 & 2) |
